Global Vertebroplasty System Market Growth 2026-2032

July 2026 | 102 pages | ID: G176A45D2B00EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Vertebroplasty System market size is predicted to grow from US$ 959 million in 2025 to US$ 1488 million in 2032; it is expected to grow at a CAGR of 6.6% from 2026 to 2032.

A vertebroplasty system is a minimally invasive medical system primarily used to stabilize vertebral compression fractures caused by osteoporosis, trauma, or spinal tumors. Under imaging guidance, the system utilizes a specialized puncture needle to inject medical bone cement into the fractured vertebra, thereby restoring vertebral strength and alleviating pain. This system offers several advantages, including rapid postoperative recovery, minimal surgical trauma, and a short hospital stay. Currently, the system is widely utilized in the fields of spinal surgery, orthopedic treatment, and interventional radiology; compared to traditional open surgical methods, it enables precise bone cement delivery and significantly enhances surgical safety. The vertebroplasty system industry chain comprises several key segments. The upstream segment primarily covers the supply of core components, such as medical bone cement materials, puncture needles, catheter systems, imaging guidance equipment, injection devices, and medical-grade polymer materials. The midstream segment focuses on system design and manufacturing, including the integration of surgical instruments, the development of bone cement delivery systems, and the integration of imaging-assisted operating systems. Downstream applications are primarily concentrated in hospital orthopedic departments, neurosurgery departments, and interventional treatment centers, where the system is employed for the minimally invasive treatment of vertebral compression fractures. The industry chain also encompasses services such as clinical training, equipment maintenance, surgical support, and consumable supplies, all aimed at ensuring surgical safety, operational precision, and continuously improving treatment outcomes. In 2025, the global production volume of vertebroplasty systems is projected to reach approximately 54,444 units, with a global average market unit price of approximately $18,000. The gross profit margins of major enterprises within this industry typically range between 40% and 60%. Also in 2025, the global production capacity for vertebroplasty systems is estimated to be approximately 72,592 units.

The Vertebroplasty System market is growing steadily due to the rising prevalence of osteoporosis-related vertebral compression fractures and increasing demand for minimally invasive spinal procedures. Aging populations are a major driver, as elderly patients are more susceptible to bone fragility and spinal injuries. Compared with traditional open surgery, vertebroplasty offers faster recovery, reduced surgical trauma, shorter hospital stays, and lower complication risks. Technological advancements in imaging guidance, bone cement materials, and precision delivery systems are improving procedural safety and clinical outcomes. In addition, the expansion of interventional radiology departments and outpatient surgical centers is supporting market adoption. The market is expected to maintain stable growth as healthcare systems increasingly shift toward minimally invasive and cost-effective treatment solutions for spinal disorders.

LP Information, Inc. (LPI) ' newest research report, the ?Vertebroplasty System Industry Forecast? looks at past sales and reviews total world Vertebroplasty System sales in 2025, providing a comprehensive analysis by region and market sector of projected Vertebroplasty System sales for 2026 through 2032. With Vertebroplasty System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vertebroplasty System industry.

This Insight Report provides a comprehensive analysis of the global Vertebroplasty System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vertebroplasty System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Vertebroplasty System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vertebroplasty System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vertebroplasty System.

This report presents a comprehensive overview, market shares, and growth opportunities of Vertebroplasty System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Expandable Vertebroplasty System
  • Conventional Vertebroplasty System
Segmentation by Surgical Procedure Type:
  • Percutaneous Vertebroplasty (PVP)
  • Balloon Kyphoplasty (BKP)
  • Vertebral Augmentation System (VAS)
Segmentation by Injection Pressure:
  • Low-Pressure Control Type: ? 0.5 MPa
  • Standard Pressure Type: 0.5?1.5 MPa
  • High-Pressure Precision Control Type: 1.5?3.0 MPa
Segmentation by Application:
  • Hospital
  • Ambulatory Surgery Center
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Johnson & Johnson
  • Shanghai Sanyou Medical Co.,ltd.
  • Double Medical Technology Inc.
  • Shandong Weigao Orthopaedic Device Co.,ltd.
  • Merit Medical
  • Andtosi
  • Medtronic
  • Stryker
  • Globus Medical
  • HOYA Technosurgical Corporation
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vertebroplasty System market?
What factors are driving Vertebroplasty System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vertebroplasty System market opportunities vary by end market size?
How does Vertebroplasty System break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Vertebroplasty System Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Vertebroplasty System by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Vertebroplasty System by Country/Region, 2021, 2025 & 2032
2.2 Vertebroplasty System Segment by Type
  2.2.1 Expandable Vertebroplasty System
  2.2.2 Conventional Vertebroplasty System
  2.2.3 Vertebroplasty System Sales by Type
    2.2.3.1 Global Vertebroplasty System Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Vertebroplasty System Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Vertebroplasty System Sale Price by Type (2021-2026)
2.3 Vertebroplasty System Segment by Surgical Procedure Type
  2.3.1 Percutaneous Vertebroplasty (PVP)
  2.3.2 Balloon Kyphoplasty (BKP)
  2.3.3 Vertebral Augmentation System (VAS)
  2.3.4 Vertebroplasty System Sales by Surgical Procedure Type
    2.3.4.1 Global Vertebroplasty System Sales Market Share by Surgical Procedure Type (2021-2026)
    2.3.4.2 Global Vertebroplasty System Revenue and Market Share by Surgical Procedure Type (2021-2026)
    2.3.4.3 Global Vertebroplasty System Sale Price by Surgical Procedure Type (2021-2026)
2.4 Vertebroplasty System Segment by Injection Pressure
  2.4.1 Low-Pressure Control Type: ? 0.5 MPa
  2.4.2 Standard Pressure Type: 0.5?1.5 MPa
  2.4.3 High-Pressure Precision Control Type: 1.5?3.0 MPa
  2.4.4 Vertebroplasty System Sales by Injection Pressure
    2.4.4.1 Global Vertebroplasty System Sales Market Share by Injection Pressure (2021-2026)
    2.4.4.2 Global Vertebroplasty System Revenue and Market Share by Injection Pressure (2021-2026)
    2.4.4.3 Global Vertebroplasty System Sale Price by Injection Pressure (2021-2026)
2.5 Vertebroplasty System Segment by Application
  2.5.1 Hospital
  2.5.2 Ambulatory Surgery Center
  2.5.3 Others
  2.5.4 Vertebroplasty System Sales by Application
    2.5.4.1 Global Vertebroplasty System Sale Market Share by Application (2021-2026)
    2.5.4.2 Global Vertebroplasty System Revenue and Market Share by Application (2021-2026)
    2.5.4.3 Global Vertebroplasty System Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Vertebroplasty System Breakdown Data by Company
  3.1.1 Global Vertebroplasty System Annual Sales by Company (2021-2026)
  3.1.2 Global Vertebroplasty System Sales Market Share by Company (2021-2026)
3.2 Global Vertebroplasty System Annual Revenue by Company (2021-2026)
  3.2.1 Global Vertebroplasty System Revenue by Company (2021-2026)
  3.2.2 Global Vertebroplasty System Revenue Market Share by Company (2021-2026)
3.3 Global Vertebroplasty System Sale Price by Company
3.4 Key Manufacturers Vertebroplasty System Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Vertebroplasty System Product Location Distribution
  3.4.2 Players Vertebroplasty System Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR VERTEBROPLASTY SYSTEM BY GEOGRAPHIC REGION

4.1 World Historic Vertebroplasty System Market Size by Geographic Region (2021-2026)
  4.1.1 Global Vertebroplasty System Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Vertebroplasty System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Vertebroplasty System Market Size by Country/Region (2021-2026)
  4.2.1 Global Vertebroplasty System Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Vertebroplasty System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Vertebroplasty System Sales Growth
4.4 APAC Vertebroplasty System Sales Growth
4.5 Europe Vertebroplasty System Sales Growth
4.6 Middle East & Africa Vertebroplasty System Sales Growth

5 AMERICAS

5.1 Americas Vertebroplasty System Sales by Country
  5.1.1 Americas Vertebroplasty System Sales by Country (2021-2026)
  5.1.2 Americas Vertebroplasty System Revenue by Country (2021-2026)
5.2 Americas Vertebroplasty System Sales by Type (2021-2026)
5.3 Americas Vertebroplasty System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Vertebroplasty System Sales by Region
  6.1.1 APAC Vertebroplasty System Sales by Region (2021-2026)
  6.1.2 APAC Vertebroplasty System Revenue by Region (2021-2026)
6.2 APAC Vertebroplasty System Sales by Type (2021-2026)
6.3 APAC Vertebroplasty System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Vertebroplasty System by Country
  7.1.1 Europe Vertebroplasty System Sales by Country (2021-2026)
  7.1.2 Europe Vertebroplasty System Revenue by Country (2021-2026)
7.2 Europe Vertebroplasty System Sales by Type (2021-2026)
7.3 Europe Vertebroplasty System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Vertebroplasty System by Country
  8.1.1 Middle East & Africa Vertebroplasty System Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Vertebroplasty System Revenue by Country (2021-2026)
8.2 Middle East & Africa Vertebroplasty System Sales by Type (2021-2026)
8.3 Middle East & Africa Vertebroplasty System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vertebroplasty System
10.3 Manufacturing Process Analysis of Vertebroplasty System
10.4 Industry Chain Structure of Vertebroplasty System

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Vertebroplasty System Distributors
11.3 Vertebroplasty System Customer

12 WORLD FORECAST REVIEW FOR VERTEBROPLASTY SYSTEM BY GEOGRAPHIC REGION

12.1 Global Vertebroplasty System Market Size Forecast by Region
  12.1.1 Global Vertebroplasty System Forecast by Region (2027-2032)
  12.1.2 Global Vertebroplasty System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Vertebroplasty System Forecast by Type (2027-2032)
12.7 Global Vertebroplasty System Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Information
  13.1.2 Johnson & Johnson Vertebroplasty System Product Portfolios and Specifications
  13.1.3 Johnson & Johnson Vertebroplasty System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Johnson & Johnson Main Business Overview
  13.1.5 Johnson & Johnson Latest Developments
13.2 Shanghai Sanyou Medical Co.,ltd.
  13.2.1 Shanghai Sanyou Medical Co.,ltd. Company Information
  13.2.2 Shanghai Sanyou Medical Co.,ltd. Vertebroplasty System Product Portfolios and Specifications
  13.2.3 Shanghai Sanyou Medical Co.,ltd. Vertebroplasty System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Shanghai Sanyou Medical Co.,ltd. Main Business Overview
  13.2.5 Shanghai Sanyou Medical Co.,ltd. Latest Developments
13.3 Double Medical Technology Inc.
  13.3.1 Double Medical Technology Inc. Company Information
  13.3.2 Double Medical Technology Inc. Vertebroplasty System Product Portfolios and Specifications
  13.3.3 Double Medical Technology Inc. Vertebroplasty System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Double Medical Technology Inc. Main Business Overview
  13.3.5 Double Medical Technology Inc. Latest Developments
13.4 Shandong Weigao Orthopaedic Device Co.,ltd.
  13.4.1 Shandong Weigao Orthopaedic Device Co.,ltd. Company Information
  13.4.2 Shandong Weigao Orthopaedic Device Co.,ltd. Vertebroplasty System Product Portfolios and Specifications
  13.4.3 Shandong Weigao Orthopaedic Device Co.,ltd. Vertebroplasty System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Shandong Weigao Orthopaedic Device Co.,ltd. Main Business Overview
  13.4.5 Shandong Weigao Orthopaedic Device Co.,ltd. Latest Developments
13.5 Merit Medical
  13.5.1 Merit Medical Company Information
  13.5.2 Merit Medical Vertebroplasty System Product Portfolios and Specifications
  13.5.3 Merit Medical Vertebroplasty System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Merit Medical Main Business Overview
  13.5.5 Merit Medical Latest Developments
13.6 Andtosi
  13.6.1 Andtosi Company Information
  13.6.2 Andtosi Vertebroplasty System Product Portfolios and Specifications
  13.6.3 Andtosi Vertebroplasty System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Andtosi Main Business Overview
  13.6.5 Andtosi Latest Developments
13.7 Medtronic
  13.7.1 Medtronic Company Information
  13.7.2 Medtronic Vertebroplasty System Product Portfolios and Specifications
  13.7.3 Medtronic Vertebroplasty System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Medtronic Main Business Overview
  13.7.5 Medtronic Latest Developments
13.8 Stryker
  13.8.1 Stryker Company Information
  13.8.2 Stryker Vertebroplasty System Product Portfolios and Specifications
  13.8.3 Stryker Vertebroplasty System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Stryker Main Business Overview
  13.8.5 Stryker Latest Developments
13.9 Globus Medical
  13.9.1 Globus Medical Company Information
  13.9.2 Globus Medical Vertebroplasty System Product Portfolios and Specifications
  13.9.3 Globus Medical Vertebroplasty System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Globus Medical Main Business Overview
  13.9.5 Globus Medical Latest Developments
13.10 HOYA Technosurgical Corporation
  13.10.1 HOYA Technosurgical Corporation Company Information
  13.10.2 HOYA Technosurgical Corporation Vertebroplasty System Product Portfolios and Specifications
  13.10.3 HOYA Technosurgical Corporation Vertebroplasty System Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 HOYA Technosurgical Corporation Main Business Overview
  13.10.5 HOYA Technosurgical Corporation Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Vertebroplasty System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Vertebroplasty System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Expandable Vertebroplasty System
Table 4. Major Players of Conventional Vertebroplasty System
Table 5. Global Vertebroplasty System Sales by Type (2021-2026) & (Units)
Table 6. Global Vertebroplasty System Sales Market Share by Type (2021-2026)
Table 7. Global Vertebroplasty System Revenue by Type (2021-2026) & ($ million)
Table 8. Global Vertebroplasty System Revenue Market Share by Type (2021-2026)
Table 9. Global Vertebroplasty System Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Percutaneous Vertebroplasty (PVP)
Table 11. Major Players of Balloon Kyphoplasty (BKP)
Table 12. Major Players of Vertebral Augmentation System (VAS)
Table 13. Global Vertebroplasty System Sales by Surgical Procedure Type (2021-2026) & (Units)
Table 14. Global Vertebroplasty System Sales Market Share by Surgical Procedure Type (2021-2026)
Table 15. Global Vertebroplasty System Revenue by Surgical Procedure Type (2021-2026) & ($ million)
Table 16. Global Vertebroplasty System Revenue Market Share by Surgical Procedure Type (2021-2026)
Table 17. Global Vertebroplasty System Sale Price by Surgical Procedure Type (2021-2026) & (US$/Unit)
Table 18. Major Players of Low-Pressure Control Type: ? 0.5 MPa
Table 19. Major Players of Standard Pressure Type: 0.5?1.5 MPa
Table 20. Major Players of High-Pressure Precision Control Type: 1.5?3.0 MPa
Table 21. Global Vertebroplasty System Sales by Injection Pressure (2021-2026) & (Units)
Table 22. Global Vertebroplasty System Sales Market Share by Injection Pressure (2021-2026)
Table 23. Global Vertebroplasty System Revenue by Injection Pressure (2021-2026) & ($ million)
Table 24. Global Vertebroplasty System Revenue Market Share by Injection Pressure (2021-2026)
Table 25. Global Vertebroplasty System Sale Price by Injection Pressure (2021-2026) & (US$/Unit)
Table 26. Global Vertebroplasty System Sale by Application (2021-2026) & (Units)
Table 27. Global Vertebroplasty System Sale Market Share by Application (2021-2026)
Table 28. Global Vertebroplasty System Revenue by Application (2021-2026) & ($ million)
Table 29. Global Vertebroplasty System Revenue Market Share by Application (2021-2026)
Table 30. Global Vertebroplasty System Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Vertebroplasty System Sales by Company (2021-2026) & (Units)
Table 32. Global Vertebroplasty System Sales Market Share by Company (2021-2026)
Table 33. Global Vertebroplasty System Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Vertebroplasty System Revenue Market Share by Company (2021-2026)
Table 35. Global Vertebroplasty System Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Vertebroplasty System Producing Area Distribution and Sales Area
Table 37. Players Vertebroplasty System Products Offered
Table 38. Vertebroplasty System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Vertebroplasty System Sales by Geographic Region (2021-2026) & (Units)
Table 42. Global Vertebroplasty System Sales Market Share Geographic Region (2021-2026)
Table 43. Global Vertebroplasty System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Vertebroplasty System Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Vertebroplasty System Sales by Country/Region (2021-2026) & (Units)
Table 46. Global Vertebroplasty System Sales Market Share by Country/Region (2021-2026)
Table 47. Global Vertebroplasty System Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Vertebroplasty System Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Vertebroplasty System Sales by Country (2021-2026) & (Units)
Table 50. Americas Vertebroplasty System Sales Market Share by Country (2021-2026)
Table 51. Americas Vertebroplasty System Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Vertebroplasty System Sales by Type (2021-2026) & (Units)
Table 53. Americas Vertebroplasty System Sales by Application (2021-2026) & (Units)
Table 54. APAC Vertebroplasty System Sales by Region (2021-2026) & (Units)
Table 55. APAC Vertebroplasty System Sales Market Share by Region (2021-2026)
Table 56. APAC Vertebroplasty System Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Vertebroplasty System Sales by Type (2021-2026) & (Units)
Table 58. APAC Vertebroplasty System Sales by Application (2021-2026) & (Units)
Table 59. Europe Vertebroplasty System Sales by Country (2021-2026) & (Units)
Table 60. Europe Vertebroplasty System Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Vertebroplasty System Sales by Type (2021-2026) & (Units)
Table 62. Europe Vertebroplasty System Sales by Application (2021-2026) & (Units)
Table 63. Middle East & Africa Vertebroplasty System Sales by Country (2021-2026) & (Units)
Table 64. Middle East & Africa Vertebroplasty System Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Vertebroplasty System Sales by Type (2021-2026) & (Units)
Table 66. Middle East & Africa Vertebroplasty System Sales by Application (2021-2026) & (Units)
Table 67. Key Market Drivers & Growth Opportunities of Vertebroplasty System
Table 68. Key Market Challenges & Risks of Vertebroplasty System
Table 69. Key Industry Trends of Vertebroplasty System
Table 70. Vertebroplasty System Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Vertebroplasty System Distributors List
Table 73. Vertebroplasty System Customer List
Table 74. Global Vertebroplasty System Sales Forecast by Region (2027-2032) & (Units)
Table 75. Global Vertebroplasty System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Vertebroplasty System Sales Forecast by Country (2027-2032) & (Units)
Table 77. Americas Vertebroplasty System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Vertebroplasty System Sales Forecast by Region (2027-2032) & (Units)
Table 79. APAC Vertebroplasty System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Vertebroplasty System Sales Forecast by Country (2027-2032) & (Units)
Table 81. Europe Vertebroplasty System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Vertebroplasty System Sales Forecast by Country (2027-2032) & (Units)
Table 83. Middle East & Africa Vertebroplasty System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Vertebroplasty System Sales Forecast by Type (2027-2032) & (Units)
Table 85. Global Vertebroplasty System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Vertebroplasty System Sales Forecast by Application (2027-2032) & (Units)
Table 87. Global Vertebroplasty System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Johnson & Johnson Basic Information, Vertebroplasty System Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Vertebroplasty System Product Portfolios and Specifications
Table 90. Johnson & Johnson Vertebroplasty System Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Johnson & Johnson Main Business
Table 92. Johnson & Johnson Latest Developments
Table 93. Shanghai Sanyou Medical Co.,ltd. Basic Information, Vertebroplasty System Manufacturing Base, Sales Area and Its Competitors
Table 94. Shanghai Sanyou Medical Co.,ltd. Vertebroplasty System Product Portfolios and Specifications
Table 95. Shanghai Sanyou Medical Co.,ltd. Vertebroplasty System Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Shanghai Sanyou Medical Co.,ltd. Main Business
Table 97. Shanghai Sanyou Medical Co.,ltd. Latest Developments
Table 98. Double Medical Technology Inc. Basic Information, Vertebroplasty System Manufacturing Base, Sales Area and Its Competitors
Table 99. Double Medical Technology Inc. Vertebroplasty System Product Portfolios and Specifications
Table 100. Double Medical Technology Inc. Vertebroplasty System Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Double Medical Technology Inc. Main Business
Table 102. Double Medical Technology Inc. Latest Developments
Table 103. Shandong Weigao Orthopaedic Device Co.,ltd. Basic Information, Vertebroplasty System Manufacturing Base, Sales Area and Its Competitors
Table 104. Shandong Weigao Orthopaedic Device Co.,ltd. Vertebroplasty System Product Portfolios and Specifications
Table 105. Shandong Weigao Orthopaedic Device Co.,ltd. Vertebroplasty System Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Shandong Weigao Orthopaedic Device Co.,ltd. Main Business
Table 107. Shandong Weigao Orthopaedic Device Co.,ltd. Latest Developments
Table 108. Merit Medical Basic Information, Vertebroplasty System Manufacturing Base, Sales Area and Its Competitors
Table 109. Merit Medical Vertebroplasty System Product Portfolios and Specifications
Table 110. Merit Medical Vertebroplasty System Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Merit Medical Main Business
Table 112. Merit Medical Latest Developments
Table 113. Andtosi Basic Information, Vertebroplasty System Manufacturing Base, Sales Area and Its Competitors
Table 114. Andtosi Vertebroplasty System Product Portfolios and Specifications
Table 115. Andtosi Vertebroplasty System Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Andtosi Main Business
Table 117. Andtosi Latest Developments
Table 118. Medtronic Basic Information, Vertebroplasty System Manufacturing Base, Sales Area and Its Competitors
Table 119. Medtronic Vertebroplasty System Product Portfolios and Specifications
Table 120. Medtronic Vertebroplasty System Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Medtronic Main Business
Table 122. Medtronic Latest Developments
Table 123. Stryker Basic Information, Vertebroplasty System Manufacturing Base, Sales Area and Its Competitors
Table 124. Stryker Vertebroplasty System Product Portfolios and Specifications
Table 125. Stryker Vertebroplasty System Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Stryker Main Business
Table 127. Stryker Latest Developments
Table 128. Globus Medical Basic Information, Vertebroplasty System Manufacturing Base, Sales Area and Its Competitors
Table 129. Globus Medical Vertebroplasty System Product Portfolios and Specifications
Table 130. Globus Medical Vertebroplasty System Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Globus Medical Main Business
Table 132. Globus Medical Latest Developments
Table 133. HOYA Technosurgical Corporation Basic Information, Vertebroplasty System Manufacturing Base, Sales Area and Its Competitors
Table 134. HOYA Technosurgical Corporation Vertebroplasty System Product Portfolios and Specifications
Table 135. HOYA Technosurgical Corporation Vertebroplasty System Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. HOYA Technosurgical Corporation Main Business
Table 137. HOYA Technosurgical Corporation Latest Developments

LIST OF FIGURES

Figure 1. Picture of Vertebroplasty System
Figure 2. Vertebroplasty System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vertebroplasty System Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Vertebroplasty System Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Vertebroplasty System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Vertebroplasty System Sales Market Share by Country/Region (2025)
Figure 10. Vertebroplasty System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Expandable Vertebroplasty System
Figure 12. Product Picture of Conventional Vertebroplasty System
Figure 13. Global Vertebroplasty System Sales Market Share by Type in 2026
Figure 14. Global Vertebroplasty System Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Percutaneous Vertebroplasty (PVP)
Figure 16. Product Picture of Balloon Kyphoplasty (BKP)
Figure 17. Product Picture of Vertebral Augmentation System (VAS)
Figure 18. Global Vertebroplasty System Sales Market Share by Surgical Procedure Type in 2026
Figure 19. Global Vertebroplasty System Revenue Market Share by Surgical Procedure Type (2021-2026)
Figure 20. Product Picture of Low-Pressure Control Type: ? 0.5 MPa
Figure 21. Product Picture of Standard Pressure Type: 0.5?1.5 MPa
Figure 22. Product Picture of High-Pressure Precision Control Type: 1.5?3.0 MPa
Figure 23. Global Vertebroplasty System Sales Market Share by Injection Pressure in 2026
Figure 24. Global Vertebroplasty System Revenue Market Share by Injection Pressure (2021-2026)
Figure 25. Vertebroplasty System Consumed in Hospital
Figure 26. Global Vertebroplasty System Market: Hospital (2021-2026) & (Units)
Figure 27. Vertebroplasty System Consumed in Ambulatory Surgery Center
Figure 28. Global Vertebroplasty System Market: Ambulatory Surgery Center (2021-2026) & (Units)
Figure 29. Vertebroplasty System Consumed in Others
Figure 30. Global Vertebroplasty System Market: Others (2021-2026) & (Units)
Figure 31. Global Vertebroplasty System Sale Market Share by Application (2025)
Figure 32. Global Vertebroplasty System Revenue Market Share by Application in 2025
Figure 33. Vertebroplasty System Sales by Company in 2025 (Units)
Figure 34. Global Vertebroplasty System Sales Market Share by Company in 2025
Figure 35. Vertebroplasty System Revenue by Company in 2025 ($ millions)
Figure 36. Global Vertebroplasty System Revenue Market Share by Company in 2025
Figure 37. Global Vertebroplasty System Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Vertebroplasty System Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Vertebroplasty System Sales 2021-2026 (Units)
Figure 40. Americas Vertebroplasty System Revenue 2021-2026 ($ millions)
Figure 41. APAC Vertebroplasty System Sales 2021-2026 (Units)
Figure 42. APAC Vertebroplasty System Revenue 2021-2026 ($ millions)
Figure 43. Europe Vertebroplasty System Sales 2021-2026 (Units)
Figure 44. Europe Vertebroplasty System Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Vertebroplasty System Sales 2021-2026 (Units)
Figure 46. Middle East & Africa Vertebroplasty System Revenue 2021-2026 ($ millions)
Figure 47. Americas Vertebroplasty System Sales Market Share by Country in 2025
Figure 48. Americas Vertebroplasty System Revenue Market Share by Country (2021-2026)
Figure 49. Americas Vertebroplasty System Sales Market Share by Type (2021-2026)
Figure 50. Americas Vertebroplasty System Sales Market Share by Application (2021-2026)
Figure 51. United States Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Vertebroplasty System Sales Market Share by Region in 2025
Figure 56. APAC Vertebroplasty System Revenue Market Share by Region (2021-2026)
Figure 57. APAC Vertebroplasty System Sales Market Share by Type (2021-2026)
Figure 58. APAC Vertebroplasty System Sales Market Share by Application (2021-2026)
Figure 59. China Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 63. India Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Vertebroplasty System Sales Market Share by Country in 2025
Figure 67. Europe Vertebroplasty System Revenue Market Share by Country (2021-2026)
Figure 68. Europe Vertebroplasty System Sales Market Share by Type (2021-2026)
Figure 69. Europe Vertebroplasty System Sales Market Share by Application (2021-2026)
Figure 70. Germany Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 71. France Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Vertebroplasty System Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Vertebroplasty System Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Vertebroplasty System Sales Market Share by Application (2021-2026)
Figure 78. Egypt Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Vertebroplasty System Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Vertebroplasty System in 2026
Figure 84. Manufacturing Process Analysis of Vertebroplasty System
Figure 85. Industry Chain Structure of Vertebroplasty System
Figure 86. Channels of Distribution
Figure 87. Global Vertebroplasty System Sales Market Forecast by Region (2027-2032)
Figure 88. Global Vertebroplasty System Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Vertebroplasty System Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Vertebroplasty System Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Vertebroplasty System Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Vertebroplasty System Revenue Market Share Forecast by Application (2027-2032)


More Publications